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Abstract
Helicobacter pylori, the causative agent of type B gastritis, peptic ulcers, gastric adenocarcinoma and MALT lymphoma, uses
the Cag type IV secretion system to induce a strong proinflammatory response in the gastric mucosa and to inject its
effector protein CagA into gastric cells. CagA translocation results in altered host cell gene expression profiles and
cytoskeletal rearrangements, and it is considered as a major bacterial virulence trait. Recently, it has been shown that
binding of the type IV secretion apparatus to integrin receptors on target cells is a crucial step in the translocation process.
Several bacterial proteins, including the Cag-specific components CagL and CagI, have been involved in this interaction.
Here, we have examined the localization and interactions of CagI in the bacterial cell. Since the cagI gene overlaps and is co-
transcribed with the cagL gene, the role of CagI for type IV secretion system function has been difficult to assess, and
conflicting results have been reported regarding its involvement in the proinflammatory response. Using a marker-free gene
deletion approach and genetic complementation, we show now that CagI is an essential component of the Cag type IV
secretion apparatus for both CagA translocation and interleukin-8 induction. CagI is distributed over soluble and
membrane-associated pools and seems to be partly surface-exposed. Deletion of several genes encoding essential Cag
components has an impact on protein levels of CagI and CagL, suggesting that both proteins require partial assembly of the
secretion apparatus. Finally, we show by co-immunoprecipitation that CagI and CagL interact with each other. Taken
together, our results indicate that CagI and CagL form a functional complex which is formed at a late stage of secretion
apparatus assembly.
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Introduction
The human gastric pathogen H. pylori is the principal cause of
chronic active gastritis and peptic ulcer disease, and it is involved
in development of gastric adenocarcinoma and mucosa-associated
lymphoid tissue (MALT) lymphoma [1,2]. The molecular
mechanisms leading to development of ulcers or cancer are not
well-understood, but both host and bacterial factors are likely to
contribute to disease development [3]. One of the major bacterial
virulence factors is the cag (cytotoxin-associated gene) pathogenicity
island, a 37 kb genomic island present only in a subset of H. pylori
isolates and clearly associated with an enhanced risk of developing
peptic ulcers or adenocarcinoma. The cag pathogenicity island
encodes the Cag type IV secretion system, which induces secretion
of chemokines such as interleukin-8 (IL-8) from gastric epithelial
cells and is thus responsible for a strong proinflammatory response
during infection, and the effector protein CagA which is
translocated into epithelial and potentially other host cells. Several
cellular interaction partners of CagA and associated changes in
cellular functions have been described, but its exact function in the
infection process is not clear. However, due to its correlation with
the risk of cancer development [4], its role in pathogenesis in
a Mongolian gerbil infection model [5], and direct evidence from
transgenic mice [6], CagA is often considered as a bacterial
oncoprotein [7].
Similar to other type IV secretion systems, components of the
Cag system assemble into a multiprotein secretion apparatus
spanning both bacterial membranes [8]. Since the Cag system
contains proteins with common features or sequence similarities to
most or all essential components of prototypical type IV secretion
systems, such as the VirB system of Agrobacterium tumefaciens or
plasmid conjugation systems, it is believed that the structure of the
secretion apparatus and its molecular mechanisms of action are
analogous. This implies the presence of a core complex bridging
the cytoplasmic and outer membranes [9], of pilus-like structures
at the bacterial cell surface [10,11], and of cytoplasmic or inner
membrane-associated ATPases providing the energy for secretion
apparatus assembly and protein transport. The pilus-like appen-
dages on the bacterial surface seem to contain several apparatus
proteins, but their exact composition has not been determined
[10–12]. Interestingly, however, several proteins that have been
shown or suspected to be part of these surface structures, interact
with b1 integrins on the host cell surface. Proteins contributing to
this interaction include the substrate CagA as well as the proteins
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CagL, CagY and CagI [13,14]. Whereas CagY has a C-terminal
domain with sequence similarity to VirB10 family proteins and
CagL has been considered as a VirB5-like adhesin of the type IV
secretion apparatus [15], CagI is a unique component without any
sequence similarities to components of prototypical type IV
systems, or to any other known protein. Although isogenic cagI
mutants have been examined in several studies, there are
conflicting reports about CagI requirement for type IV secretion
system function. One study found that deletion of the cagI gene
resulted in an impairment of CagA translocation, but not IL-8
induction [16], and two others found that the presence of cagI is
required for IL-8 induction as well [17,18]. Since cagI is part of an
operon containing several other genes involved in type IV
secretion [19], and since none of these studies included
complementation of a cagI mutant, the actual contribution of
CagI to these phenotypes is not clear. However, a recent study
which included complementation of a cagI mutant provided direct
evidence that CagI is required for IL-8 induction [20].
In this study, we have constructed a set of cagI mutants with the
aim of avoiding polar effects on expression of the essential
downstream gene cagL, and we have complemented the mutants to
gain insight into CagI function. Infection experiments show that
CagI is an essential component of the Cag type IV secretion
apparatus, required for both IL-8 induction and CagA trans-
location. We provide evidence that CagI is, at least partly,
associated with the bacterial outer membrane, and exposed to the
bacterial surface. Moreover, we show that it interacts with the
putative integrin ligand CagL. These data suggest that both
proteins may form a complex at the bacterial cell surface, and that
this complex is required for productive interactions with target
cells.
Results
Deletion of the CagI gene Results in Low CagL Levels
There have been conflicting results concerning the requirement
of CagI for induction of IL-8 secretion from gastric epithelial cells
in previous studies [16–18]. One reason for this discrepancy might
be differences in the H. pylori strains used in each study, but it
might also be due to subtle differences in gene expression patterns
in the respective cagI mutants, given that cagI is part of an operon
structure with several alternative transcriptional start sites [19].
Closer inspection of the cagI locus shows that the 39 end of cagI
overlaps with the start codon of cagL, and the Shine-Dalgarno
sequence of cagI overlaps with the stop codon of cagH (Fig. 1A).
Thus, cagI deletion and replacement by a resistance gene cassette
may have polar effects on expression of the cagL gene. We sought
to re-evaluate the contribution of cagI for type IV secretion system
function by constructing cagI mutants devoid of such polar effects.
To check for production of the CagI protein, we raised an
antiserum against a synthetic peptide corresponding to a C-
terminal CagI region (amino acids 350–368; see Materials and
Methods). This antiserum recognized a 42 kDa protein in
immunoblots from whole cell lysates of strain P12 or its isogenic
cagA mutant, but not from lysates of an isogenic P12 cagI mutant
generated with the deletion plasmid pSO171 (Table 1) (Fig. 1B).
Control immunoblots with a CagL antiserum showed a strong
reduction of CagL levels in the cagI mutant (Fig. 1B), suggesting
that insertion of the chloramphenicol resistance cassette in the cagI
locus exerted a downstream transcriptional effect. Alternatively, it
is possible that the absence of the CagI protein influences CagL
production and/or stability.
Since CagL is essential for both CagA translocation and
induction of IL-8 secretion [16], the role of CagI for type IV
secretion system function could thus not unambiguously be
demonstrated with this mutant. To overcome this problem, we
used a marker-free deletion procedure involving the streptomycin
counter-selection system [21] to construct cagI deletion mutants.
Since an alternative transcriptional start site for cagL has been
identified in the 39 region of the cagI gene [19], we constructed
mutants in strain P12 in which the 59 cagI part was either replaced
by a streptomycin sensitivity/erythromycin resistance cassette
(using plasmid pWS320), or deleted without insertion of a re-
sistance marker (using plasmid pWS326; Fig. 1C). Western blot
analysis with the polyclonal CagI antiserum demonstrated that
CagI production was lost in these mutants, as expected, but cagI
deletion again resulted in strongly reduced CagL protein levels
(Fig. 2A, lanes 2 and 4). Complementation of the cagI mutants with
a chromosomal (recA) integration vector containing the cagI gene
under the control of the cagA promoter (plasmid pWS322; Fig. 1C)
resulted not only in CagI production, but also in restored CagL
production (Fig. 2A; lanes 3 and 5). This suggested that the
reduced CagL levels observed in the cagI mutants were not caused
by transcriptional effects of resistance gene cassette insertion or
gene deletion, but rather by direct effects of CagI on CagL.
To corroborate this conclusion, we sought to quantify cagL
transcript levels in these mutants. For this purpose, we prepared
total RNA from liquid cultures of the different H. pylori strains,
carried out reverse transcription into cDNA, and performed
conventional as well as real-time PCR with cagL-specific primers
and control primers specific for 16S-rRNA. In control PCRs, we
obtained cagL-specific bands from cDNA, but not mRNA from
P12 wild-type bacteria, confirming that the RNA preparation was
not contaminated by genomic DNA (data not shown). Transcript
quantification by qPCR showed no significant difference in cagL
levels between wild-type bacteria and each cagI mutant (Fig. 2B),
demonstrating that deletion of the 59 cagI region did not interfere
with transcription of the cagL gene.
CagI is Required for CagA Translocation and IL-8
Induction
To examine the impact of cagI deletion on functionality of the
Cag type IV secretion system, we performed infection experiments
of AGS epithelial cells with H. pylori for 4 hours, and determined
tyrosine phosphorylation of the CagA protein by Western blot
analysis and induction of IL-8 secretion by sandwich ELISA.
Infection experiments with the wild-type strain and the pWS320
and pWS326 mutants showed that cagI deletion results in a CagA
translocation deficiency, as shown previously (Fig. 3A). In
addition, these cagI mutants were unable to induce IL-8 secretion
from AGS cells (Fig. 3B). Complementation of these mutants
restored both CagA translocation and IL-8 induction after AGS
cell infection (Figs. 3A and 3B).
While these results indicated an involvement of CagI in both
type IV secretion-associated phenotypes, it could still not be ruled
out that the differing CagL levels are in fact responsible for these
phenotypes. Therefore, we complemented the pWS320 cagI
mutant with a chromosomal integration vector harboring the cagL
gene under the control of the cagA promoter. The resulting strain
produced an intermediate amount of CagL, but was nevertheless
defective for CagA translocation and IL-8 induction (data not
shown), suggesting that CagI is independently required for type IV
secretion system function. Furthermore, we generated a marker-
free cagI deletion mutant (using plasmid pWS327; Fig. 1C) in
which cagI was deleted in such a way that the cagI Shine-Dalgarno
sequence is used as a ribosomal binding site for cagL, providing
a ‘‘bypass’’ in the operon from cagH directly to cagL. Surprisingly,
this cagI mutant produced normal levels of CagL (Fig. 2A),
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indicating that CagI is not absolutely required for CagL
production or stability. However, quantification of cagL transcripts
by qPCR showed a 6.04 6 4.67-fold increase of cagL mRNA levels
in the pWS327 mutant in comparison to wild-type bacteria
(Fig. 2B), suggesting that precise deletion of the cagI gene resulted
in a more effective transcription of the cagL gene, possibly via the
cagF promoter. Interestingly, the cagI mutant obtained with
plasmid pWS327 was also completely defective in both CagA
translocation and IL-8 induction (Figs. 3A and 3B). Taken
together, these results show that CagI is by itself an essential
component of the Cag type IV secretion apparatus.
CagI and CagL Protein Levels in H. Pylori Cells Depend on
the Presence of Various Secretion Apparatus
Components
Mutual interdependence of protein levels is often found in
multiprotein complexes such as type IV secretion machines, and
has often been interpreted as stabilizing effects due to the presence
of corresponding protein-protein interactions [22–25]. To de-
termine if such effects occur between other Cag components and
either CagI or CagL, we generated isogenic mutants of strain P12
in each cag gene known to have at least a partial function for Cag
type IV secretion (Table 1), and we examined cell lysates of these
mutants for CagI and CagL production by immunoblotting. As
shown in Fig. 4, CagI production was influenced by the absence of
several cag genes. Notably, the cagX, cagY, cagH and cagG mutants
produced virtually no CagI, and several further mutants (Dcagd,
DcagW, DcagV, DcagU, DcagM, DcagL and DcagE) produced
significantly reduced amounts of CagI. In contrast, the cagF
mutant produced normal levels of CagI. This suggests that inner
membrane-associated structural components (CagU, CagV,
CagW, CagY), components of a putative outer membrane-
associated subcomplex (CagX, CagM, Cagd), and also CagL,
may have an impact on CagI stability. Interestingly, CagL levels
were strongly reduced in the cagY and cagX mutants as well (Fig. 4),
whereas control measurements by qPCR showed that the levels of
cagL transcripts were not significantly different in these mutants
(data not shown). Significant reductions of CagL levels were also
found in the cagd, cagW, cagI, cagH, cagG and cagE mutants, but not
in other mutants showing reduced CagI levels (DcagV, DcagU,
DcagM), and again not in the cagF mutant (Fig. 4).
CagI is Present in Different Subcellular Pools and is Partly
Surface-exposed
To obtain evidence for CagI and CagL localization, we
fractionated bacterial cells into soluble and membrane-associated
Table 1. Strains and plasmids used in this study.
Strain/Plasmid Description Source/Reference
P12 wild-type strain [34]
P12Dcagd P12 transformed with plasmid pWS145 [16] This study
P12Dcagc P12 transformed with plasmid pJP94 [16] This study
P12Dcagb P12 transformed with plasmid pJP93a [16] [25]
P12Dcaga P12 transformed with plasmid pRB24 [16] This study
P12DcagZ P12 transformed with plasmid pRB25 [16] [25]
P12DcagY pJP89a P12 transformed with plasmid pJP89a [16] This study
P12DcagX P12 transformed with plasmid pJP90 [16] This study
P12DcagW P12 transformed with plasmid pRB22 [16] This study
P12DcagV P12 transformed with plasmid pRB26 [16] This study
P12DcagU P12 transformed with plasmid pWS139 [16] This study
P12DcagT P12 transformed with plasmid pJP95 [16] This study
P12DcagM P12 transformed with plasmid pBG11 [16] This study
P12DcagN P12 transformed with plasmid pBG10 [16] This study
P12DcagL P12 transformed with plasmid pWS290 [14]
P12DcagI P12 transformed with plasmid pSO171 [16] This study
P12DcagH P12 transformed with plasmid pSO172 [16] This study
P12DcagG P12 transformed with plasmid pSO173 [16] This study
P12DcagF P12 transformed with plasmid pSO174 [16] [26]
P12DcagE P12 transformed with plasmid pBG17 [16] This study
P12DcagD P12 transformed with plasmid pSO176 [16] This study
P12DcagC P12 transformed with plasmid pBG16 [16] This study
P12DcagA P12 transformed with plasmid pJP52 [16] [33]
pWS320 cagI (59) deletion plasmid; rpsL-erm insertion This study
pWS322 recA insertion plasmid; cagI behind cagA promoter This study
pWS325 cagI (59) deletion plasmid; cat insertion This study
pWS326 cagI (59) deletion plasmid (marker-free) This study
pWS327 cagI deletion plasmid (marker-free) This study
doi:10.1371/journal.pone.0035341.t001
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components, and extracted the total membrane fraction with 1%
triton X-100, which preferentially extracts cytoplasmic membrane
proteins [26]. In these fractionations, CagI was found both in the
membrane fraction and in the soluble fraction containing
cytoplasmic and periplasmic proteins (Fig. 5A). Membrane-
associated CagI was not completely extracted by triton X-100,
suggesting that CagI might be partly associated with the outer
membrane. In contrast, the majority of CagL was found in the
soluble fraction, and only a minor part in the total membrane
fraction from where it was not extracted by triton X-100 (Fig. 5A).
The distribution of CagL in the fractions was not significantly
different in the wild type and the cagI mutant. Control
immunoblots showed that the outer membrane-associated proteins
CagX and AlpB were present only in the membrane fraction, and
were not extracted by triton X-100, whereas the inner membrane-
associated protein RecA was substantially extracted from the
membrane fraction. As an independent method for membrane
separation, we used isopycnic sucrose density gradient centrifuga-
tion of resuspended total membrane fractions. Immunoblot
analysis of individual fractions from the sucrose gradients revealed
two different membrane-associated pools of both CagI and CagL
(Fig. 5B). Control immunoblots showed that only the high density
fractions contained outer membrane-associated proteins, whereas
the cytoplasmic membrane-associated protein RecA was present in
several fractions.
While these results suggested the presence of separate CagI and
CagL pools in different localizations in the bacterial cell, they did
not reveal a clear association with the outer membrane or the
bacterial surface. To obtain evidence for a possible localization at
the surface, we performed a limited proteolytic digestion of intact
bacterial cells with proteinase K. Protease accessibility of CagI and
CagL was assessed by immunoblotting of equal amounts of
untreated and proteinase K-treated cells. The amounts of both
CagI and (to a lesser extent) CagL were significantly reduced by
proteinase K treatment, whereas the cytoplasmic or cytoplasmic
membrane-associated protein RecA was not digested, and the
outer membrane protein AlpB was digested almost completely
(Fig. 5C). Taken together, these data indicate that both CagI and
CagL are partially localized at the bacterial surface, but that
considerable pools of both proteins exist in a non-surface
localization as well.
CagI Interacts with CagL
The influence of CagX, CagY and CagL on CagI protein levels,
and of CagI on CagL protein levels, suggested that corresponding
protein-protein interactions might exist. To determine whether
Figure 1. Operon organization of the cagH, cagI and cagL genes. (A) Gene arrangement of the cag pathogenicity island in H. pylori strain P12.
Genes are represented as arrows, and their designations are indicated below. The operon containing cagI may comprise five (cagF, cagG, cagH, cagI
and cagL) or even more genes, but cagH, cagI and cagL are particularly tightly associated since they have overlapping reading frames or Shine-
Dalgarno (SD) sequences. Translational starts are indicated by arrows. (B) A cagI deletion mutant containing a terminatorless chloramphenicol
resistance cassette [16] was generated by transformation with plasmid pSO171. A polyclonal rabbit antiserum raised against CagI was used for
immunoblot analysis of whole cell lysates of the P12 wild-type strain or isogenic cagA or cagI mutants. The same lysates were examined by Western
blot for the presence of CagL using the polyclonal rabbit antiserum AK271. CagI and CagL protein bands, respectively, are marked by arrowheads.
Note that both antisera recognize cross-reactive bands, but anti-CagI does not react with CagL or vice versa (data not shown). (C) Plasmid constructs
used for generation and complementation of cagI mutants. A counterselection strategy was used for generating marker-free deletion mutants.
Mutants generated with plasmids pWS320 and pWS326 retain the 39 part of cagI, whereas the mutant generated with plasmid pWS327 has
a complete deletion without any cagI traces. For complementation of cagI mutants in trans, the cagI gene was cloned under the control of the cagA
promoter and integrated into the recA gene (plasmid pWS322).
doi:10.1371/journal.pone.0035341.g001
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CagX and/or CagY interact with CagI, we performed immuno-
precipitation experiments from H. pylori cell extracts with
polyclonal CagX and CagY antisera, as described previously
[24]. Western blot analysis of the precipitated proteins showed
a co-precipitation of CagX with CagY and vice versa, but we were
unable to detect CagI in the precipitation fractions (data not
shown). To determine whether CagI interacts with CagL, we used
the polyclonal CagI antiserum for immunoprecipitation experi-
ments. Immunoblot analysis of the precipitated proteins showed
that CagI was successfully precipitated, and that CagL was indeed
co-precipitated with CagI (Fig. 6). In a control immunoprecipi-
tation from the cagI mutant, CagL was not co-precipitated,
demonstrating the specificity of the immunoprecipitation. To
confirm this result, we performed a reverse immunoprecipitation
using the polyclonal CagL antiserum AK271, which precipitated
CagL together with a cross-reacting protein (Fig. 6). Consistent
with the results described above, CagI was co-precipitated with
CagL from an H. pylori P12 wild-type lysate. Again, immunopre-
cipitation from a lysate of the P12DcagL mutant did not result in
precipitation of CagI. Taken together, these data demonstrate that
CagI and CagL form a complex in H. pylori cells.
Discussion
Type IV secretion systems are known as a highly versatile group of
macromolecule transporters [27,28], and this versatility is also
Figure 2. Analysis of CagI and CagL production, and of cagL
transcription, in cagI mutants and complemented strains. (A)
Whole cell lysates of the P12 wild-type strain and the indicated cagI
mutants or complemented mutants were examined for CagI and CagL
production by immunoblot analysis. Numbers in brackets indicate the
plasmids used for mutant generation or complementation. (B) The
indicated strains were grown in liquid culture to mid-exponential phase,
and harvested for total RNA preparation and cDNA synthesis. Transcript
levels of cagL were analyzed by quantitative real-time PCR (qPCR) and
normalized to levels of 16S-rRNA for each cDNA sample. Bars represent
mean values and standard deviations of cagL transcript levels in relation
to wild-type levels for at least three independent RNA preparations.
doi:10.1371/journal.pone.0035341.g002
Figure 3. CagI is an essential component of the Cag type IV
secretion apparatus. (A) AGS cells were infected for 4 h with the
indicated strains at a multiplicity of infection of 100, and infection
lysates were examined by immunoblot for the presence of CagA and
CagA tyrosine phosphorylation (PTyr). Infected cells were also examined
by light microscopy for induction of the hummingbird phenotype. (B)
Culture supernatants of AGS cells infected with the indicated H. pylori
strains as above were tested for their IL-8 content. IL-8 values induced
by wild-type P12 were set to 100%, and other values are given in
relation to wild-type levels. Data shown are average values of at least
three independent experiments with standard deviations.
doi:10.1371/journal.pone.0035341.g003
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reflected in the variation of their respective components.Many well-
characterized type IV secretion systems including some conjugation
systems are composed of conserved essential components. In
contrast, more divergent systems such as the Icm/Dot (type IVb)
system of Legionella pneumophila, or the Cag system ofH. pylori, usually
include additional components with as yet unknown functions. The
Cag system probably contains functional analogues to all VirB
proteins and to VirD4 [8], but also additional essential components
that are unique to this system. These additional components include
twoproteins (Cagd/Cag3andCagM)whichhavebeen shown to take
part in an outer membrane-associated subcomplex [24,29], two
predicted inner membrane proteins (CagU and CagH), and one
protein (CagD)withapossible surface localization[30].Usingcareful
mutation and complementation studies, we show here that CagI is
another essential component of theCag type IV secretion apparatus.
Furthermore, we show that CagI interacts with CagL, an essential
Cag secretion apparatus component that, like CagI, has been shown
to bind to integrin receptors on the target cell surface [13]. A recent
study, which also included complementation of cagI mutants [20],
reached the same conclusions.
The chromosomal region containing the cagI gene seems to be
organized as an operon of five genes (cagF, cagG, cagH, cagI and
cagL) [19], with the latter three open reading frames overlapping
each other, indicating that there is a tight coupling of cagH, cagI
and cagL gene expression. Although we found effects of cagG and
cagH deletion on CagI and CagL protein levels, and of cagI deletion
on CagL protein levels, cagF deletion did not seem to have much
influence on the levels of either protein, arguing against simple
transcriptional effects. This is also supported by our cagL transcript
quantification data showing only minor differences between the
wild-type strain and different cagI mutants, and by complemen-
tation of the cagI deletion mutants which restored CagL pro-
duction without changing cagL transcript levels. Although we
cannot exclude that translation of cagL transcripts or other post-
transcriptional processes are less effective in the cagI deletion
mutants, it is likely that the presence of the CagI protein and its
interaction with CagL accounts at least partly for maintenance of
CagL wild-type levels. A surprising finding was that the complete
marker-free deletion of cagI (using plasmid pWS327) did not
influence CagL protein levels. Since cagL transcript levels were
Figure 4. Presence of several Cag components influences CagI and CagL protein levels. Whole cell lysates of equal amounts of the wild-
type strain P12 and of isogenic mutants in single cag genes (Table 1) were separated by SDS-PAGE and examined by immunoblotting with the anti-
CagI and anti-CagL antisera, respectively. Representative immunoblots are shown. Note that the cagImutant shown here was generated with plasmid
pWS327. Arrowheads indicate the positions of CagI and CagL protein bands, respectively.
doi:10.1371/journal.pone.0035341.g004
Figure 5. Localization of CagI and CagL in bacterial cell fractions. (A) H. pylori cells grown in liquid culture for 24–48 hours were lysed by
ultrasonication and subsequently fractionated into soluble and insoluble proteins by ultracentrifugation. Ultracentrifugation pellets containing
membrane-associated and other insoluble proteins were extracted with 1% triton X-100 to separate outer membrane-associated (TX100 insol) from
inner membrane-associated (TX100 sol) proteins. Comparable amounts of each fraction were analysed by immunoblot for their CagI and CagL
content. As controls, immunoblots against the outer membrane-associated proteins CagX and AlpB, and the partly soluble and partly inner
membrane-associated protein RecA were used. Representative immunoblots are shown. CagI and CagL bands are indicated by arrowheads. (B)
Ultracentrifugation pellets were resuspended and subjected to isopycnic density gradient centrifugation on 25–60% sucrose gradients. Fractions
were collected from the gradients and analyzed by immunoblotting with the indicated antisera. CagI and CagL bands are indicated by arrowheads.
(C) Bacteria were subjected to limited proteolytic digestion by proteinase K. Equal amounts of untreated control cells (P12) and proteinase K-treated
bacteria (P12 PK) were analyzed by immunoblot with the indicated antisera.
doi:10.1371/journal.pone.0035341.g005
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increased in this mutant, the most likely explanation is that
a combination of higher cagL transcription and increased CagL
degradation due to the lacking interaction with CagI resulted in
almost wild-type levels of the CagL protein. It is not clear which
effect was responsible for the differing phenotype reported
previously for the cagI mutant in strain 26695 [16], but
reconstruction of 26695 cagI deletion mutants resulted in the
same phenotypes as described here (data not shown), arguing
against strain-specific differences.
It is reasonable to assume that the genetic organization of cagG,
cagH, cagI and cagL also reflects a functional connection between
the gene products. Previous yeast two-hybrid screening procedures
[25,31] detected interactions between CagI and several other Cag
proteins including CagG, but none of them was confirmed except
an interaction between recombinant CagI and CagZ fusion
proteins in vitro [31]. We show here that the native CagI and CagL
proteins take part in a protein complex in H. pylori cells, as also
found in a recent study where immunoprecipitation of CagL from
H. pylori lysates resulted in coprecipitation of CagI and CagH [20].
CagG, CagH, CagI, and CagL are all acidic proteins with
predicted isoelectric points between 4 and 6. CagG, CagI and
CagL contain N-terminal signal sequences and would thus be
supposed to be transported to the periplasm, from where the latter
two might reach the bacterial surface, as would be expected for
integrin ligands. In contrast, CagH is most likely an integral
cytoplasmic membrane protein, according to topology predictions
[24]. An interesting feature of CagI is that its C-terminal amino
acids (SKVIVK) are almost identical to the C-terminal amino
acids of CagL (SK(I/V)IVK) and CagH (TKIIVK); the latter two
proteins also show a weak overall sequence similarity between
each other (data not shown). Intriguingly, these C-terminal motifs
have been shown to contribute to the function of these proteins
[20], raising the possibility that they represent binding motifs for
a common interaction partner of all three proteins.
Given that CagI and CagL were found to interact by co-
immunoprecipitation, it is worth noting that the two proteins were
not distributed equally in bacterial cell fractions. The majority of
CagL was found in a soluble fraction, which also contained CagI,
but more CagI seemed to be associated with the membrane
fractions under the conditions used. Due to their N-terminal signal
sequences, the most likely localization of the soluble pools of both
proteins is in the periplasm. The membrane-associated pools of
CagI and CagL showed a similar distribution in sucrose density
gradient fractions, although CagI was more readily extracted from
a total membrane fraction with triton X-100. However, as
described previously [24,26], it is not possible to completely
separate cytoplasmic and outer membrane proteins of H. pylori
using such standard procedures. Therefore, a clear assignment of
the membrane pools to cytoplasmic membrane or outer
membrane-derived vesicles, respectively, is not possible at this
point, but the protease digestion experiments strongly suggest
a partial surface exposition of the CagI protein. CagI showed
a higher susceptibility for surface proteinase K digestion than
CagL, but since CagL has been localized on surface appendages
formed by the Cag secretion apparatus [13] and probably
functions as a pilus-associated adhesin binding to integrin
receptors [15], we would expect that CagL is also surface-exposed.
It is not clear at this point whether CagI localizes to type IV
secretion apparatus pili as well, and if so, whether the interaction
between CagI and CagL takes place there, or if there is only an
indirect interaction, mediated by a common interaction partner of
both proteins. Unfortunately, possibly due to the cross-reactions of
the CagI antiserum, we have so far been unable to localize CagI at
the bacterial surface by immunofluorescence. Thus, it remains to
be shown whether CagI is really associated with the pilus-like type
IV surface appendages.
The decreased CagI levels in mutants lacking components of the
putative type IV secretion apparatus core complex (DcagV, DcagW,
DcagX, DcagY, and possibly DcagE), or in mutants lacking
components of the putative outer membrane-associated subcom-
plex (Dcagd, DcagM, DcagX), might be taken as an indication that
corresponding protein-protein interactions exist. However, since
we were unable to detect any interaction between CagI (or CagL)
and CagX or CagY by immunoprecipitation (data not shown), an
alternative possibility is that wild-type CagI levels reflect correct
protein localization, implying that CagI is transported by the
secretion apparatus itself. In this scenario, an incompletely
assembled secretion apparatus would result in failure of CagI to
reach its destination, to form the putative CagI-CagL complex,
and, as a consequence, in protein degradation. CagI and CagL
would thus represent ‘‘late’’ components in secretion apparatus
assembly, an assumption that is also supported by the observation
that type IV secretion pili are not produced in the absence of CagI
or CagL [20]. Further studies are required to elucidate the order
in which the different Cag proteins assemble into a functional
secretion or translocation complex.
In conclusion, we have demonstrated that CagI is an essential
component of the Cag type IV secretion apparatus. Dependence
of CagI protein levels on multiple cag genes and its interaction
with CagL suggest that these two proteins take part in
a subcomplex at the bacterial surface which might, possibly
together with further components such as CagY, tether the
secretion apparatus to integrin receptors to initiate translocation
of CagA into host cells.
Figure 6. CagI interacts with CagL. Cell extracts of the wild-type strain P12 and its isogenic cagI (pWS327) and cagL mutants were subjected to
immunoprecipitation (IP) with either anti-CagI or anti-CagL antisera. Cell extracts and immunoprecipitates were analysed by immunoblotting with
anti-CagI and anti-CagL antisera.
doi:10.1371/journal.pone.0035341.g006
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Materials and Methods
Bacterial Strains, Cell Lines and Transformation
H. pylori strains were grown on GC agar plates (Difco)
supplemented with vitamin mix (1%), horse serum (8%),
vancomycin (10 mg/l), trimethoprim (5 mg/l), and nystatin
(1 mg/l) (serum plates), and incubated for 16 to 60 h in
a microaerobic atmosphere (85% N2, 10% CO2, 5% O2) at
37uC. E. coli strains Top10 (Invitrogen) and DH5a (BRL) were
grown on Luria-Bertani (LB) agar plates or in LB liquid medium
[32] supplemented with ampicillin (100 mg/l), chloramphenicol
(30 mg/l), or kanamycin (40 mg/l), as appropriate. AGS epithelial
cells (obtained from ATCC; number CRL-1739) were cultivated
under standard conditions as described previously [33]. For the
generation of isogenic mutants in H. pylori strain P12, the
corresponding plasmids (Table 1) were introduced by natural
transformation, as described [34]. H. pylori transformants were
selected on serum agar plates containing 6 mg/l chloramphenicol
or 8 mg/l kanamycin.
Plasmid Constructions
Standard cloning and DNA analysis procedures were performed
according to [32]. Plasmid DNA was purified from E. coli by the
boiling procedure and E. coli cells for electroporation were
prepared according to the protocol recommended for the Gene
Pulser (BioRad). Amplification of DNA fragments by polymerase
chain reaction (PCR) was performed as described [34]. The cagI
deletion plasmids pWS320, pWS325 and pWS326 were based on
inverse PCR amplification of a gene library plasmid used for
sequencing of strain P12 [35] with primers WS418 (59-
ACCGGTCGAC TAAAAAACAT TTCATATCTC-39) and
WS419 (59-ACCGGTCGAC GGATCCGACA ACGCTCAATA
CATCG-39). The PCR product, which contained thus cagI
flanking regions and the pSMART-HCKan cloning vector, was
either digested with SalI and religated for plasmid pWS326, or
digested with BamHI and SalI and subsequently ligated with
a chloramphenicol resistance cassette to obtain plasmid pWS325,
or with an rpsL-erm cassette to obtain plasmid pWS320. The
precise deletion construct pWS327 was obtained by inverse PCR
from the same gene library plasmid using the 59-phosphorylated
primers WS420 (59-CATATCTCTT TCCTCACTTC-39) and
WS421 (59-AAAACACTCG TGAAAAATAC C-39), and blunt-
end religation of the PCR product. For complementation of the
cagI mutants, plasmid pWS322 was constructed by PCR
amplification of the cagI gene using primers WS311 (59-
GGACTAGTGA AGTGAGGAAA GAGATGTG-39) and
WS308 (59-ACCGCTCGAG TCATTTGACA ATAACTT-
TAG-39), and cloning the PCR product via SpeI and XhoI into
pWS241 [36], a derivative of the chromosomal recA integration
vector pJP99 [37], which enables, after integration into the H.
pylori recA locus, expression of cloned genes under the control of the
cagA promoter.
Antisera and Immunoblotting
The antiserum against CagI was generated by immunization of
a rabbit with a synthetic peptide comprising 19 C-terminal amino
acids of CagI (amino acids 350–368; H2N-(C)NLEKKADL-
WEEQLKLERET-COOH) coupled to KLH, as described pre-
viously [24]. Rabbit polyclonal antisera against CagL, CagX,
CagA, RecA, and AlpB have been described previously
[10,24,38]. Sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and Western blotting was performed as
described [16]. For the development of immunoblots, polyviny-
lidene difluoride (PVDF) filters were blocked with 5% non-fat milk
powder in TBS (50 mM Tris-HCl, pH 7.5, 150 mM NaCl), 0.1%
(v/v) Tween 20, and incubated with the respective antisera at
a dilution of 1:1000–1:5000. Alkaline phosphatase-conjugated
protein A or horseradish peroxidase-conjugated anti-rabbit IgG
antiserum was used to visualize bound antibody.
Tyrosine Phosphorylation Assay and Determination of IL-
8 Secretion
Standard infections of AGS cells with H. pylori strains and
subsequent preparations for phosphotyrosine immunoblotting
were performed as described previously [33]. Briefly, cells were
infected with bacteria at a multiplicity of infection of 100 for 4
h at 37uC, washed three times and suspended in PBS
containing 1 mM EDTA, 1 mM Na3VO4, 1 mM PMSF,
10 mg/ml leupeptin, 10 mg/ml pepstatin. Cells with adherent
bacteria were collected by centrifugation and resuspended in
sample solution. Tyrosine-phosphorylated proteins were ana-
lyzed by immunoblotting with the phosphotyrosine antiserum
PY99 (Santa Cruz Biotechnologies). The production of IL-8 by
AGS cells after infection with H. pylori strains for 4h was
determined from cell supernatants by a sandwich ELISA as
described [16].
RNA Isolation
Total RNA was isolated from H. pylori strains grown in liquid
cultures for 16–24 h by the hot phenol method [19]. Briefly,
bacterial cells were mixed with a stop solution containing 95%
ethanol and 5% phenol and collected by centrifugation. Pellets
were resuspended in 600 ml TE (pH 8.0) containing 0.5 mg/ml
lysozyme; suspensions were mixed with 60 ml 10% SDS, incubated
at 64uC for 2 min, mixed with 66 ml 1M sodium acetate (pH 5.2),
and extracted with 750 ml phenol at 64uC. Traces of phenol were
removed from the aqueous phases by extraction with 750 ml
chloroform and centrifugation at 120006g for 15 min. RNA was
precipitated from the aqueous phases with ethanol/sodium acetate
(pH 6.5), redissolved in diethylpyrocarbonate-treated water, and
treated with RNase-free DNase I (Fermentas). Total RNA was
analyzed on nondenaturing 1.0% agarose gels and quantified on
a NanoDrop ND 1000 spectrophotometer (Thermo Scientific).
cDNA Synthesis and qPCR
For cDNA synthesis, we used the First Strand cDNA Synthesis
Kit (Fermentas) with 1–5 mg total RNA and random hexamer
primers. Reverse transcription was carried out at 25uC for 5 min
and at 37uC for 60 min, and the reaction was terminated by
heating to 70uC for 5 min. Primers for qPCR were designed to
amplify 90 bp to 150 bp regions of the cagL gene as well as 16S-
rRNA (internal control). Reaction mixes containing a master mix
with SYBR green (Invitrogen, Hamburg, Germany) and each set
of primers were added to a 96-well plate together with diluted
cDNA samples at a final volume of 25 ml per well. Nuclease-free
water was used as negative control. Samples were incubated in an
ABI-Prism SDS7000 (Applied Biosystems, Darmstadt, Germany)
for 43 cycles (30 s at 95uC, 30 s at 59uC, and 30 s at 72uC).
Transcript levels were quantified by the comparative CT (cycle
threshold) method and normalized to 16S-rRNA levels in each
sample. The relative abundance of each transcript was calculated
using the 2-DCT formula.
Bacterial Cell Fractionation
Bacterial cells were fractionated as described previously [26],
with minor modifications. Briefly, H. pylori cells were grown in
Brucella broth for 24–48 h, then harvested, washed and
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resuspended in preparation buffer (10 mM Tris-HCl, pH 8.0,
1 mM PMSF, 1 mM leupeptin, 1 mM pepstatin). Bacteria were
lysed by ultrasonication, and the lysate was centrifuged for 10 min
at 7000 6 g to remove unbroken cells and cell debris. The
supernatant was collected and separated by ultracentrifugation
(60 min, 230000 6 g) into soluble (cytoplasmic and periplasmic)
and total membrane fractions. Proteins in the soluble fractions
were concentrated by chloroform-methanol precipitation [39],
while the membrane fractions were washed with and resuspended
in preparation buffer. For differential extraction, triton X-100 was
added to the membrane suspension to a final concentration of 1%
(wt/vol), and the mixture was incubated on ice for 30 min and
fractionated by ultracentrifugation (45 min, 2300006g). Sucrose
density gradients were prepared by layering solutions containing
decreasing sucrose concentrations (60% (w/v) to 25% (w/v)) in
triethanolamine buffer (50 mM triethanolamine, pH 7.5; 1 mM
EDTA) upon one another in SW41 rotor tubes, followed by
overnight equilibration at 4uC. Total membranes resuspended in
triethanolamine buffer were layered on top of the gradients, and
the tubes were centrifuged at 4uC (18 h, 2700006 g). Fractions
were collected from the density gradients, and proteins were
concentrated by precipitation as above.
Limited Proteinase K Digestion
For limited proteinase K digestion, bacteria were grown on
agar plates for 24 hours, harvested and washed in PBS, and
resuspended at a density of 6 6 107 cells per ml in proteinase
K buffer (50 mM Tris-HCl, pH 7.4; 150 mM NaCl, 1 mM
CaCl2, 1 mM MgCl2, 1 mM KCl) containing 1 mg/ml pro-
teinase K (Sigma). This suspension was incubated at room
temperature for 30 min. To stop the reaction, PMSF was added
to a final concentration of 1 mM. Bacteria were collected by
centrifugation at 5000 6 g for 20 min at 4uC. Pellets were
resuspended in radioimmunoprecipitation (RIPA) buffer (50 mM
Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Nonidet
P-40, 0.25% sodium deoxycholate, 1 mM PMSF, 10 mg/ml
leupeptin, 10 mg/ml pepstatin) and mixed with SDS-PAGE
sample solution.
Immunoprecipitation
Bacteria grown on agar plates were suspended in PBS and
washed twice. An amount of 561010 bacteria was resuspended in
radioimmunoprecipitation (RIPA) buffer (50 mM Tris-HCl,
pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40,
0.25% sodium deoxycholate, 1 mM PMSF, 10 mg/ml leupeptin,
10 mg/ml pepstatin) and the cells were lysed by sonication.
Unbroken cells were removed by centrifugation for 10 min at
10000 6 g. To remove unspecifically interacting proteins, the
lysates were incubated with prewashed protein G-agarose (Roche
Diagnostics) for 2h at 4uC, and then centrifuged. To the
supernatants, 5 ml of the appropriate polyclonal antisera was
added, and samples were incubated for 3h at 4uC. Then, 50 ml of
prewashed protein G-agarose was added and samples were
incubated at 4uC for additional 2h. After three washing steps
with RIPA buffer, proteins were eluted with 100 mM glycine,
pH 2.7, or by boiling in SDS-PAGE sample solution.
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